Medicine & Life Sciences
Influenza A virus
100%
SARS Virus
47%
Human Influenza
37%
Virion
36%
Severe Acute Respiratory Syndrome
34%
Viruses
34%
Orthomyxoviridae
34%
Coronavirus
32%
Neuraminidase
31%
Hemagglutinins
29%
Infections
27%
Venezuelan Equine Encephalitis Viruses
25%
Virus Diseases
23%
masitinib
20%
Saliva
18%
Coinfection
17%
Defective Viruses
17%
Infectious Encephalitis
17%
Virus Shedding
16%
Viral Proteins
16%
Antibodies
15%
RNA
15%
Population
14%
Product Packaging
12%
Viral Genes
12%
Antiviral Agents
11%
Viral Load
11%
Viral Genome
11%
Glycosylation
11%
Influenza B virus
9%
Coronavirus Infections
9%
Superinfection
8%
Genome
8%
Central Nervous System
8%
Pandemics
8%
Costs and Cost Analysis
7%
Complementarity Determining Regions
7%
Drug Repositioning
7%
Encephalomyelitis
7%
Untranslated Regions
7%
Nose
7%
Vaccines
7%
Neuropathology
7%
Genes
6%
Gene Expression
6%
Viral RNA
6%
Complement Activation
6%
Virus Assembly
5%
Tissue Distribution
5%
Agriculture & Biology
Influenza A virus
61%
hemagglutinins
24%
Venezuelan equine encephalitis virus
17%
Orthomyxoviridae
15%
infection
12%
Influenza B virus
12%
sialidase
11%
antibodies
11%
glycosylation
10%
viruses
9%
virion
8%
encephalitis
7%
central nervous system
7%
blood-brain barrier
7%
antigenic variation
7%
influenza
7%
mixed infection
6%
nucleoproteins
6%
therapeutics
6%
gene expression
6%
viral proteins
6%
interferons
6%